JP2022507269A5 - - Google Patents

Info

Publication number
JP2022507269A5
JP2022507269A5 JP2021525757A JP2021525757A JP2022507269A5 JP 2022507269 A5 JP2022507269 A5 JP 2022507269A5 JP 2021525757 A JP2021525757 A JP 2021525757A JP 2021525757 A JP2021525757 A JP 2021525757A JP 2022507269 A5 JP2022507269 A5 JP 2022507269A5
Authority
JP
Japan
Prior art keywords
mir
sequence
target sequence
copies
recombinant dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021525757A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022507269A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/061093 external-priority patent/WO2020102285A1/en
Publication of JP2022507269A publication Critical patent/JP2022507269A/ja
Publication of JP2022507269A5 publication Critical patent/JP2022507269A5/ja
Pending legal-status Critical Current

Links

JP2021525757A 2018-11-13 2019-11-13 カプセル化ポリヌクレオチド及び使用方法 Pending JP2022507269A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862760422P 2018-11-13 2018-11-13
US62/760,422 2018-11-13
PCT/US2019/061093 WO2020102285A1 (en) 2018-11-13 2019-11-13 Encapsulated polynucleotides and methods of use

Publications (2)

Publication Number Publication Date
JP2022507269A JP2022507269A (ja) 2022-01-18
JP2022507269A5 true JP2022507269A5 (cg-RX-API-DMAC7.html) 2022-11-07

Family

ID=70731661

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021525757A Pending JP2022507269A (ja) 2018-11-13 2019-11-13 カプセル化ポリヌクレオチド及び使用方法

Country Status (12)

Country Link
US (1) US20210403950A1 (cg-RX-API-DMAC7.html)
EP (1) EP3880812A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022507269A (cg-RX-API-DMAC7.html)
KR (1) KR20210093285A (cg-RX-API-DMAC7.html)
CN (1) CN113348246A (cg-RX-API-DMAC7.html)
AU (1) AU2019381698A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021009226A2 (cg-RX-API-DMAC7.html)
CA (1) CA3117924A1 (cg-RX-API-DMAC7.html)
IL (1) IL282992A (cg-RX-API-DMAC7.html)
MX (1) MX2021005448A (cg-RX-API-DMAC7.html)
SG (1) SG11202104887UA (cg-RX-API-DMAC7.html)
WO (1) WO2020102285A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11130787B2 (en) * 2020-06-11 2021-09-28 MBF Therapeutics, Inc. Alphaherpesvirus glycoprotein d-encoding nucleic acid constructs and methods
TWI918825B (zh) * 2021-02-10 2026-03-21 美商艾勒維生技公司 化合物、組合物及其使用方法
CN118324715A (zh) * 2021-02-10 2024-07-12 艾勒维生技公司 化合物、组合物及其使用方法
IT202200016386A1 (it) * 2022-08-02 2024-02-02 Univ Degli Studi Roma La Sapienza Nanoparticelle lipidiche multicomponenti ad elevata fusogenicità cellulare per la veicolazione di acidi nucleici e relativo processo di preparazione
EP4658782A2 (en) * 2023-02-02 2025-12-10 The Regents of the University of California Self-amplifying non-coding rna for targeted gene knockdown
WO2024194273A1 (en) * 2023-03-20 2024-09-26 Dimberg Anna Tumor blood vessel-targeted aav therapy for cancer treatment
CN117487762A (zh) * 2023-11-06 2024-02-02 中科佰乘(深圳)生物科技有限公司 一种细胞外囊泡、制备方法、药物组合物及应用
CN119242712A (zh) * 2024-09-27 2025-01-03 南京师范大学 特异性靶向骨骼肌细胞的携带miRNA-486基因的腺相关病毒载体、药物组合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1092777A1 (en) * 1999-10-15 2001-04-18 Aventis Pharma S.A. Self-cleaving RNA sequences and their use for the control of protein synthesis.
AU2002953436A0 (en) * 2002-12-18 2003-01-09 The University Of Newcastle Research Associates Limited A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis
AU2004274860A1 (en) * 2003-05-28 2005-03-31 Wisconsin Alumni Research Foundation Recombinant influenza vectors with a polII promoter and ribozymes
DK1668025T3 (da) * 2003-09-26 2014-08-25 Novartis Ag Seneca Valley-virusbaserede præparater og fremgangsmåder til behandling af sygdom
CN102166218A (zh) * 2005-01-17 2011-08-31 溶瘤病毒有限公司 治疗肿瘤的方法和组合物
WO2006138380A2 (en) * 2005-06-15 2006-12-28 Massachusetts Institute Of Technology Amine-containing lipids and uses thereof
EP3302575A4 (en) * 2015-05-28 2019-01-16 Coda Biotherapeutics GEMONEDITIERUNGSVEKTOREN
HK1246183A1 (zh) * 2015-06-10 2018-09-07 Hookipa Biotech Gmbh Hpv疫苗
AU2017212713B2 (en) * 2016-01-27 2023-01-19 Oncorus, Inc. Oncolytic viral vectors and uses thereof
EP3478321A4 (en) * 2016-06-30 2020-04-22 Oncorus, Inc. PSEUDOTYPIZED ONCOLYTIC VIRAL ADMINISTRATION OF THERAPEUTIC POLYPEPTIDES
CA3030003A1 (en) * 2016-07-08 2018-01-11 F1 Oncology, Inc. Methods and compositions for transducing lymphocytes and regulating the activity thereof
WO2018087753A1 (en) * 2016-11-08 2018-05-17 Technology Innovation Momentum Fund (Israel) Limited Partnership Cationic lipids for nucleic acid delivery and preparation thereof
RU2020106730A (ru) * 2017-07-14 2021-08-16 Онкорус, Инк. Инкапсулированные полинуклеотиды и способы их применения
CN114765990A (zh) * 2019-10-10 2022-07-19 昂克诺斯公司 双重病毒和双重溶瘤病毒以及治疗方法

Similar Documents

Publication Publication Date Title
US11713336B2 (en) Peptides and nanoparticles for intracellular delivery of molecules
JP2022516318A5 (cg-RX-API-DMAC7.html)
Wu et al. Chimeric antigen receptor therapy meets mRNA technology
Yao et al. Recent progress in mRNA cancer vaccines
Oveili et al. The potential use of mesenchymal stem cells-derived exosomes as microRNAs delivery systems in different diseases
JP2021524245A5 (cg-RX-API-DMAC7.html)
JP2024503623A5 (cg-RX-API-DMAC7.html)
Steinle et al. Delivery of synthetic mRNAs for tissue regeneration
Tyagi et al. Exploiting nanotechnology for the development of microRNA-based cancer therapeutics
US11931409B2 (en) Compositions and methods for organ-protective expression and modulation of coding ribonucleic acids
JP2017524341A5 (cg-RX-API-DMAC7.html)
JP2018504896A5 (cg-RX-API-DMAC7.html)
WO2019023483A1 (en) ONCOLYTIC VIRAL VECTORS AND USES THEREOF
JP2023528300A5 (cg-RX-API-DMAC7.html)
CN112533643A (zh) 外排体用于靶向递送治疗剂的用途
Dai et al. Pancreatic cancer: Nucleic acid drug discovery and targeted therapy
Janowski et al. The legacy of mRNA engineering: A lineup of pioneers for the Nobel Prize
CN116218904A (zh) 一种可提高工程化细胞外泌体中特定核酸分子载量的方法及其应用
Liu et al. Biological response modifier in cancer immunotherapy
CN119709763B (zh) 一种预防或治疗恶性肿瘤的mRNA疫苗及其制备方法与应用
RU2021116984A (ru) Инкапсулированные полинуклеотиды и способы их применения
Li et al. Extracellular vesicles in pancreatic cancer function and potential clinical applications
Javanmardi et al. Progresses in microRNA delivery using synthetic nanovectors in cancer therapy
Wu et al. Unlocking the potential of RNA-based therapeutics in the lung: current status and future
HK1245305A1 (en) Peptides and nanoparticles for intracellular delivery of molecules